share_log

Connect Biopharma | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Qiming Corporate GP V, Ltd(5.8%),Qiming GP V, L.P.(5.6%), etc.

康乃德生物 | SC 13G/A:超過5%持股股東披露文件(修正)-Qiming Corporate GP V, Ltd(5.8%),Qiming GP V, L.P.(5.6%)等

2023/02/14 06:27
声明:本內容僅用作提供資訊及教育之目的,不構成對任何特定投資或投資策略的推薦或認可。 更多信息